The Oncology Institute Serves its 150,000th Patient!

The Oncology Institute recently welcomed its 150,000th patient since its founding in August 2007

It is fitting that this milestone was reached during Breast Cancer Awareness Month given The Oncology Institute of Hope and Innovation’s (TOI) commitment to advancing treatment for breast cancer patients. TOI has treated nearly 13,000 breast cancer patients since opening its doors in 2007 and is currently conducting more than a dozen clinical trials on leading-edge treatments for a variety of breast cancers through its research arm – The Innovative Clinical Research Institute.

“Here at TOI we believe every patient deserves access to state-of-the-art cancer care in their local community,” said Brad Hively, CEO at TOI. “We are proud to have reached this milestone and look forward to bringing our personalized, compassionate care to patients across the country.”

Dr. Marathe Named 40 Under 40 in Cancer

On October 15, 2020, The Oncology Institute’s Dr. Omkar Marathe was named one of the 40 Under 40 in Cancer by the Association for Value-Based Cancer Care

A lifelong native of Southern California, Dr. Marathe earned his bachelors in neuroscience from UCLA, magna cum laude, and his MD from the David Geffen School of Medicine at UCLA. He trained in internal medicine at Scripps Green Hospital in San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program. He joined The Oncology Institute of Hope and Innovation in 2016.

Dr. Marathe provides great care to his patients every day and regularly serves as a principal investigator for clinical trials, bringing the most cutting-edge treatments to his patients. Dr. Marathe embodies our core values and we are proud to see him receive this recognition!